Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Immunosuppressive therapy for vasculitis

S Hall¹, D L Conn

¹Monash University, Melbourne, Australia.

Current Opinion in Rheumatology

|January 1, 1995

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Constraints on body size distributions: an experimental approach using a small-scale system.

Oecologia·2017

Same author

A precise measurement of the [Formula: see text] meson oscillation frequency.

The European physical journal. C, Particles and fields·2017

Same author

Observation of the Annihilation Decay Mode B^{0}→K^{+}K^{-}.

Physical review letters·2017

Same author

Observation of the Decay Ξ_{b}^{-}→pK^{-}K^{-}.

Physical review letters·2017

Same author

Measurement of the b-Quark Production Cross Section in 7 and 13 TeV pp Collisions.

Physical review letters·2017

Same author

Observation of J/ψϕ Structures Consistent with Exotic States from Amplitude Analysis of B^{+}→J/ψϕK^{+} Decays.

Physical review letters·2017

Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026

Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026

Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026

Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026

Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026

Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026

See all related articles

Controlled trials for immunosuppressive therapy in vasculitis are limited, necessitating further research into long-term outcomes and novel treatments. Understanding treatment risks, like infection, is crucial for managing this autoimmune condition.

Area of Science:

Immunology
Rheumatology
Clinical Trials

Background:

Vasculitis management lacks robust controlled trial data.
Relapse is common in various vasculitis forms.
Immunosuppressive therapy carries risks, including opportunistic infections.

Purpose of the Study:

To highlight the need for further study of long-term vasculitis outcomes.
To emphasize the necessity of controlled trials for novel vasculitis therapies.
To discuss the role of contemporary management in vasculitis.

Main Methods:

Review of existing literature on immunosuppressive therapy for vasculitis.
Analysis of the current understanding of vasculitis treatment outcomes.
Examination of case reports and small series on novel therapies.

Related Experiment Videos

Main Results:

Controlled trials for immunosuppressive therapy in vasculitis are scarce.
Long-term outcomes require further investigation with modern treatments.
The efficacy of novel therapies needs validation through multicenter studies.

Conclusions:

Further controlled studies are essential for optimal vasculitis management.
Investigating long-term outcomes and treatment-related adverse events is critical.
The precise role of novel therapies, including interferon for hepatitis C-related vasculitis, requires clarification.